Wellington Management Group LLP Forma Therapeutics Holdings, Inc. Transaction History

Wellington Management Group LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $1.36 Million - $3.87 Million	191,002 Added 214.17%	280,183 $5.59 Million
Q1 2022 May 16, 2022	BUY	$8.34 - $14.69 $319,572 - $562,891	38,318 Added 75.34%	89,181 $830,000
Q4 2021 Feb 11, 2022	BUY	$13.6 - $24.89 $691,736 - $1.27 Million	50,863 New	50,863 $723,000
Q3 2021 Nov 15, 2021	SELL	$21.22 - $25.7 $4.52 Million - $5.48 Million	-213,044 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$22.86 - $30.95 $3.58 Million - $4.85 Million	-156,596 Reduced 42.36%	213,044 $5.3 Million
Q1 2021 May 17, 2021	SELL	$24.58 - $42.82 $27.7 Million - $48.2 Million	-1,126,606 Reduced 75.3%	369,640 $10.4 Million
Q4 2020 Feb 12, 2021	SELL	$34.9 - $51.08 $12.1 Million - $17.7 Million	-346,365 Reduced 18.8%	1,496,246 $52.2 Million
Q3 2020 Nov 16, 2020	SELL	$32.95 - $50.25 $11 Million - $16.7 Million	-332,502 Reduced 15.29%	1,842,611 $90.5 Million
Q2 2020 Aug 14, 2020	BUY	$39.0 - $46.49 $84.8 Million - $101 Million	2,175,113 New	2,175,113 $98.4 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.